Skip to content

Preterm Infant Multicentre Growth Study

Preterm Infant Multicentre Growth Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03064022
Acronym
PreMGS
Enrollment
1275
Registered
2017-02-24
Start date
2009-02-28
Completion date
2019-06-30
Last updated
2020-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm Infant

Keywords

weight gain, head circumference, length, neurodevelopment, overweight

Brief summary

The purpose of this study is to improve health professionals understanding of preterm infant growth patterns, and to determine if early growth patterns predict risks of adverse metabolic and cognitive outcomes.

Detailed description

The purpose of this study is: To improve health professionals understanding of preterm infant growth patterns, and to determine if growth patterns (rapid early growth in the first 2 weeks of life, weight less than the 10th percentile at the time of discharge) predict risks of adverse metabolic outcomes (measured as overweight at age 3) once the following variables are controlled for: size at birth (z-score), neonatal morbidities, social determinants of health, and nutritional adequacy in the neonatal intensive care unit (NICU). To assess diagnostic accuracy of 36-week anthropometric weight, length and head circumference \<10th and \<3rd percentiles to predict preterm infant cognitive impairment.

Interventions

OTHERGrowth

Some preterm infants grow at higher rates than others

Sponsors

Canadian Foundation for Dietetic Research (CFDR)
CollaboratorOTHER
Saskatchewan Health Authority - Regina Area
CollaboratorOTHER
Tufts University
CollaboratorOTHER
University of Calgary
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 3 Years
Healthy volunteers
No

Inclusion criteria

* \< 32 weeks gestational age at birth

Exclusion criteria

* infants who had congenital anomalies or those who died prior to discharge

Design outcomes

Primary

MeasureTime frameDescription
NeurodevelopmentTwenty-one months of ageNeurodevelopment (Bayley scale scores II and III), diagnoses of cerebral palsy, or other neurologic impairments) measured

Secondary

MeasureTime frameDescription
OverweightThree years of ageOverweight will be defined as body mass index
Growth patternsFrom birth to 50 weeks post-menstrual ageGrowth patterns of preterm infants relative to the Fenton growth chart

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026